Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
Lab Chip. 2018 Jul 10;18(14):2047-2054. doi: 10.1039/c8lc00202a.
Human cell-based 3D tissue constructs play an increasing role in disease modeling and drug screening. Inflammation, atherosclerosis, and many autoimmune disorders involve the interactions between immune cells and blood vessels. However, it has been difficult to image and model these interactions under realistic conditions. In this study, we fabricated a perfusion and imaging chamber to allow the real-time visualization of leukocyte perfusion, adhesion, and migration inside a tissue-engineered blood vessel (TEBV). We monitored the elevated monocyte adhesion to the TEBV wall and transendothelial migration (TEM) as the TEBV endothelium was activated by the inflammatory cytokine TNF-α. We demonstrated that treatment with anti-TNF-α or an NF-kB signaling pathway inhibitor would attenuate the endothelium activation and reduce the number of leukocyte adhesion (>74%) and TEM events (>87%) close to the control. As the first demonstration of real-time imaging of dynamic cellular events within a TEBV, this work paves the way for drug screening and disease modeling in TEBV-associated microphysiological systems.
基于人类细胞的 3D 组织构建体在疾病建模和药物筛选中发挥着越来越重要的作用。炎症、动脉粥样硬化和许多自身免疫性疾病都涉及免疫细胞和血管之间的相互作用。然而,在现实条件下对这些相互作用进行成像和建模一直具有挑战性。在这项研究中,我们制造了一个灌注和成像室,以允许实时可视化组织工程化血管(TEBV)内白细胞的灌注、黏附和迁移。我们监测到单核细胞在 TEBV 壁上的黏附和跨内皮迁移(TEM)增加,因为 TEBV 内皮细胞被炎症细胞因子 TNF-α激活。我们证明,用抗 TNF-α或 NF-κB 信号通路抑制剂治疗会减弱内皮细胞的激活,并减少白细胞黏附和 TEM 事件的数量(>74%),接近对照。作为在 TEBV 内实时成像动态细胞事件的首次演示,这项工作为与 TEBV 相关的微生理系统中的药物筛选和疾病建模铺平了道路。